Abp 101 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This new analysis on IBD patients initiating biologic therapy with the biosimilar ABP 501 indicates that the drug’s lower cost and efficacy may lead to greater use.

Thousand oaksUnited statesUnited kingdomAmgen incDisease specific programmeRan jinSpecific programmeWork productivityActivity impairmentInflammatory bowel diseaseAbp 101